Log-in
Register now
Register now
Log-in

Nordic Life Science Days 2016
14-15 september 2016
Waterfront, Stockholm, Sweden

© 2021 Bionordic. All Rights Reserved

Register now
Log-in

Photo by Andreas Nordström

Logo
Register now
Log-in
Log-in

Latest news in cooperation with Nordic Life Science

News

China is certified malaria-free by WHO

26 July 2021 | 9:51 am
China is certified malaria-free by WHO
Following a 70-year effort, China has been awarded a malaria-free certification from WHO. This is a notable feat for a country that reported 30 million cases of the disease annually in the 1940s, the WHO states in a press release. “Today we congratulate the people of China on ridding the country of malaria,” says Dr […]
News

Aztiq to buy a 17% stake in Alvogen US

26 July 2021 | 5:48 am
Robert Wessman
Aztiq Pharma Partners, a private equity fund led by Róbert Wessman, announced in the beginning of July that it has completed a 100 million USD financing to purchase a newly issued share equity in Alvogen US. Morgan Stanley led the financing, which was subscribed by international institutional investors. The capital was used by Aztiq to […]
News

Novo Nordisk presents new data from the SUSTAIN FORTE trial

23 July 2021 | 5:12 am
Martin Holst Lange
The company has presented data showing that an investigational 2.0 mg dose of Ozempic provided statistically significant and superior reductions in blood sugar compared with Ozempic 1.0 mg. These data were the outcome of the SUSTAIN FORTE trial, a phase 3b, 40-week, efficacy and safety trial comparing once-weekly semaglutide 2.0 mg vs Ozempic 1.0 mg […]
News

Two different types of COVID-19 vaccines provide good protection

21 July 2021 | 11:29 am
Mattias Forsell Photo Mattias Pettersson
A new study from Umeå University shows that a first dose of AstraZeneca’s COVID-19 vaccine and a second dose of an mRNA COVID-19 vaccine gives a good immune response against COVID-19. A combination of different types of vaccines also leads to a significantly higher level of antibodies compared to having two doses of the same […]
News

Ending hepatitis – The discovery of HCV

21 July 2021 | 9:17 am
Ending hepatitis – The discovery of HCV
Piece by piece the Nobel Laureates laid the puzzle in understanding and determining the hepatitis C virus, a discovery that has saved millions of lives. The Nobel Prize in Physiology or Medicine 2020 was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of the Hepatitis C virus (HCV), a […]
News

A new Swedish immunotherapeutic cancer vaccine delivery-platform

21 July 2021 | 7:24 am
Sara Mangsbo Photo Mikael Wallerstedt
SciLifeLab Group leader, Sara Mangsbo, Uppsala University, and her immunotherapeutic cancer vaccine delivery-platform, is now ready to leave the SciLifeLab Drug Discovery and Development platform (DDD). The immunotherapeutic cancer vaccine delivery platform is based on a new technique, called Adaptable Drug Affinity Conjugate (ADAC), that can help the immune system to detect “invisible” tumors and […]
News

Inge Marie Svane receives the Marie and August Krogh Prize

20 July 2021 | 5:29 am
Inge Marie Svane
She receives the 2021 Marie and August Krogh Prize for her dedicated efforts in cancer and immunotherapy. The Prize is awarded annually to an outstanding health researcher in Denmark. The Foundation and the Organization of Danish Medical Societies award the Prize, which is accompanied by DKK 1.5 million, of which DKK 1.25 million is for […]
News

AstraZeneca’s Imfinzi approved in China

19 July 2021 | 3:44 pm
Dave Fredrickson
Imfinzi has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with standard of care platinum chemotherapy (etoposide plus a choice of either carboplatin or cisplatin). “Today’s approval of Imfinzi plus chemotherapy brings an important global standard of care to patients with extensive-stage small […]
News

IRLAB enters licensing agreement with Ipsen

19 July 2021 | 3:13 pm
Nicholas Waters
Ipsen and IRLAB have signed a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. “We are excited to enter this licensing agreement with IRLAB. By working in partnership, we aim to bring investigational mesdopetam to people living with Parkinson’s disease experiencing levodopa-induced dyskinesia,” says Howard Mayer, […]
News

AstraZeneca’s Forxiga recommended for approval in the EU

19 July 2021 | 5:18 am
AstraZeneca scientist
Forxiga has been recommended for approval in the European Union (EU) for the treatment of chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on results from the DAPA-CKD Phase III trial that showed Forxiga, […]

© 2021 SwedenBIO. All Rights Reserved

Legal Notices

© 2021 Bionordic. All Rights Reserved

Legal Notices